BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7574024)

  • 1. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration.
    Adachi T; Shinomura T; Nakao S; Kurata J; Murakawa M; Shichino T; Seo N; Mori K
    Anesth Analg; 1995 Oct; 81(4):862-5. PubMed ID: 7574024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitor does not reduce minimum alveolar anesthetic concentration of halothane in rats.
    Adachi T; Kurata J; Nakao S; Murakawa M; Shichino T; Shirakami G; Shinomura T; Mori K
    Anesth Analg; 1994 Jun; 78(6):1154-7. PubMed ID: 7515216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole.
    Ichinose F; Mi WD; Miyazaki M; Onouchi T; Goto T; Morita S
    Anesthesiology; 1998 Jul; 89(1):143-8. PubMed ID: 9667304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NitroG-L-arginine methyl ester decreases minimum alveolar concentration of isoflurane and reduces brain nitric oxide synthase activity in rats.
    Chen TY; Chang CL; Tseng CC; Tsai YC; Cheng JT
    Acta Anaesthesiol Sin; 1998 Sep; 36(3):127-31. PubMed ID: 9874859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
    Salter M; Duffy C; Hazelwood R
    Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness?
    Johns RA; Moscicki JC; DiFazio CA
    Anesthesiology; 1992 Oct; 77(4):779-84. PubMed ID: 1384399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition.
    Macleod MR; Butcher SP
    Neurosci Lett; 2002 Mar; 322(1):41-4. PubMed ID: 11958839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalational anesthetic effects on rat cerebellar nitric oxide and cyclic guanosine monophosphate production.
    Rengasamy A; Pajewski TN; Johns RA
    Anesthesiology; 1997 Mar; 86(3):689-98. PubMed ID: 9066336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane and isoflurane dose-dependently inhibit the cyclic GMP increase caused by N-methyl-D-aspartate in rat cerebellum: novel localization and quantitation by in vitro autoradiography.
    Zuo Z; De Vente J; Johns RA
    Neuroscience; 1996 Oct; 74(4):1069-75. PubMed ID: 8895875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibitors, 7-nitro indazole and nitroG-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia.
    Pajewski TN; DiFazio CA; Moscicki JC; Johns RA
    Anesthesiology; 1996 Nov; 85(5):1111-9. PubMed ID: 8916829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halothane minimum alveolar anesthetic concentration and neuronal nitric oxide synthase activity of the dorsal horn and the locus ceruleus in rats.
    Fukuda T; Saito S; Sato S; Harukuni I; Toyooka H
    Anesth Analg; 1999 Oct; 89(4):1035-9. PubMed ID: 10512286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
    Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
    J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halothane and isoflurane inhibit vasodilation due to constitutive but not inducible nitric oxide synthase. Implications for the site of anesthetic inhibition of the nitric oxide/guanylyl cyclase signaling pathway.
    Zuo Z; Tichotsky A; Johns RA
    Anesthesiology; 1996 May; 84(5):1156-65. PubMed ID: 8624010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME).
    Salter M; Duffy C; Garthwaite J; Strijbos PJ
    Neuropharmacology; 1995 Jun; 34(6):639-49. PubMed ID: 7566500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.
    Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B
    Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats.
    Drummond JC; McKay LD; Cole DJ; Patel PM
    Anesth Analg; 2005 Mar; 100(3):841-846. PubMed ID: 15728077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of cerebellar nitric oxide synthase by ethanol in vitro.
    Fataccioli V; Gentil M; Nordmann R; Rouach H
    Alcohol Alcohol; 1997; 32(6):683-91. PubMed ID: 9463722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on the righting reflex ED50 and minimum alveolar concentration during sevoflurane anaesthesia in rats.
    Kobayashi S; Katoh T; Iwamoto T; Bito H; Sato S
    Eur J Anaesthesiol; 2003 Mar; 20(3):212-9. PubMed ID: 12650492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.